Metro Inc. (TSX:MRU)
| Market Cap | 20.06B -3.5% |
| Revenue (ttm) | 22.48B +2.9% |
| Net Income | 899.10M -11.9% |
| EPS | 4.21 -8.7% |
| Shares Out | 209.63M |
| PE Ratio | 22.75 |
| Forward PE | 18.60 |
| Dividend | 1.63 (1.70%) |
| Ex-Dividend Date | Oct 22, 2026 |
| Volume | 647,845 |
| Open | 96.54 |
| Previous Close | 97.14 |
| Day's Range | 95.31 - 96.63 |
| 52-Week Range | 86.63 - 101.30 |
| Beta | 0.32 |
| Analysts | Hold |
| Price Target | 98.90 (+3.37%) |
| Earnings Date | Nov 18, 2026 |
About Metro
Metro Inc., through its subsidiaries, operates as a retailer, franchisor, distributor, and manufacturer in the food and pharmaceutical sectors in Canada. The company operates supermarkets, discount stores, neighbourhood stores, specialized stores, and pharmacies that provide fresh and grocery products, baked goods, prepared food products, meats, dairy products, fruits and vegetables, frozen food products, bakery products, prepared meals, delicatessen items, fruits and vegetables, frozen products and pastries. It also manufactures ready-to-eat m... [Read more]
Financial Performance
In fiscal year 2025, Metro's revenue was 22.01 billion, an increase of 3.71% compared to the previous year's 21.22 billion. Earnings were 1.02 billion, an increase of 9.50%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for MRU stock is "Hold." The 12-month stock price target is $98.90, which is an increase of 3.37% from the latest price.
News
Metro price target lowered to C$110 from C$111 at RBC Capital
RBC Capital lowered the firm’s price target on Metro (MTRAF) to C$110 from C$111 and keeps a Sector Perform rating on the shares.
Metro Earnings Call Transcript: Q3 2026
Q3 results were heavily impacted by a labor strike, leading to lower food same-store sales and margins, though pharmacy and online segments showed resilience. Network optimization and a bakery sale are expected to drive future earnings, while the labor conflict continues to weigh on outlook.
Metro Earnings release: Q3 2026
Metro released its Q3 2026 earnings on August 12, 2026, summarizing the period's financial results.
Metro Quarterly report: Q3 2026
Metro has published its Q3 2026 quarterly earnings report on August 12, 2026.
Metro MD&A: Q3 2026
Metro filed a regulatory document on August 12, 2026 disclosing important business information.
Metro downgraded to Market Perform from Outperform at BMO Capital
BMO Capital downgraded Metro (MTRAF) to Market Perform from Outperform with a price target of C$95, down from C$105. The company is being impacted by Loblaw’s continued discount expansion in…
Metro price target lowered to C$106 from C$113 at TD Securities
TD Securities lowered the firm’s price target on Metro (MTRAF) to C$106 from C$113 and keeps a Buy rating on the shares.
Metro price target lowered to C$97 from C$99 at Desjardins
Desjardins lowered the firm’s price target on Metro (MTRAF) to C$97 from C$99 and keeps a Hold rating on the shares.
Metro price target lowered to C$105 from C$110 at BMO Capital
BMO Capital analyst Etienne Ricard lowered the firm’s price target on Metro (MTRAF) to C$105 from C$110 and keeps an Outperform rating on the shares.
Metro price target lowered to C$96 from C$103 at Scotiabank
Scotiabank lowered the firm’s price target on Metro (MTRAF) to C$96 from C$103 and keeps a Sector Perform rating on the shares.
Metro Earnings Call Transcript: Q2 2026
Q2 saw 4.1% sales growth to CAD 5.1B, with strong pharmacy and discount banner performance, and adjusted EPS up 8.8%. Gross margin improved, online sales rose nearly 20%, and a Québec strike is expected to impact Q3.
Metro Earnings release: Q2 2026
Metro released its Q2 2026 earnings on April 22, 2026, summarizing the period's financial results.
Metro Report: Q2 2026
Metro published a report on April 22, 2026 containing material business information for investors and shareholders.
Metro MD&A: Q2 2026
Metro filed a regulatory document on April 22, 2026 disclosing important business information.
Metro price target lowered to C$112 from C$113 at RBC Capital
RBC Capital lowered the firm’s price target on Metro (MTRAF) to C$112 from C$113 and keeps a Sector Perform rating on the shares.
Metro price target lowered to C$110 from C$115 at BMO Capital
BMO Capital analyst Etienne Ricard lowered the firm’s price target on Metro (MTRAF) to C$110 from C$115 and keeps an Outperform rating on the shares.
Metro price target lowered to C$103 from C$110 at Scotiabank
Scotiabank lowered the firm’s price target on Metro (MTRAF) to C$103 from C$110 and keeps an Outperform rating on the shares.
Metro price target lowered to C$113 from C$118 at TD Securities
TD Securities lowered the firm’s price target on Metro (MTRAF) to C$113 from C$118 and keeps a Buy rating on the shares.
Metro price target lowered to C$113 from C$118 at TD Securities
TD Securities analyst Michael Van Aelst lowered the firm’s price target on Metro (MTRAF) to C$113 from C$118 and keeps a Buy rating on the shares.
Metro Earnings Call Transcript: Q1 2026
Q1 saw 3.3% sales growth and 5.5% adjusted EPS growth, despite a costly freezer disruption. Food and pharmacy segments both posted positive same-store sales, with discount and online channels outperforming. Dividend was raised 10.1% and share buybacks continued.
Metro Earnings release: Q1 2026
Metro released its Q1 2026 earnings on January 27, 2026, summarizing the period's financial results.
Metro Report: Q1 2026
Metro published a report on January 27, 2026 containing material business information for investors and shareholders.
Metro MD&A: Q1 2026
Metro filed a regulatory document on January 27, 2026 disclosing important business information.
Metro Earnings Call Transcript: Q4 2025
Q4 saw 3.4% sales growth and 8.6% higher adjusted net earnings, despite a CAD 22.5 million after-tax impact from a Toronto freezer shutdown. Discount and pharmacy segments led growth, with strong online and private label performance. FY 2026 guidance includes higher CapEx and continued store expansion.
Metro Earnings release: Q4 2025
Metro released its Q4 2025 earnings on November 19, 2025, summarizing the period's financial results.